Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 02, 2024 09:00 ET | Source: GlucoTrack, Inc.

GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION

Continuous blood glucose monitor’s preclinical data and sensor longevity modeling to be presented at major diabetes conference Rutherford, NJ, May 02, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc....
June 15, 2023 08:00 ET | Source: Nemaura Medical, Inc

Nemaura Medical to Exhibit and Provide Live Product Demonstrations of Its Non-invasive Glucose Sensor at the 83rd Scientific Sessions of the American Diabetes Association June 23-26, 2023

LOUGHBOROUGH, June 15, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive...
September 20, 2021 14:43 ET | Source: Simplify Healthcare

Simplify Healthcare supports Maker’s Merci in donating $5K to the American Diabetes Association to improve the lives of diabetics

Aurora, IL, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Simplify Healthcare is proud to support its not-for-profit affiliate, Maker’s Merci in donating $5,000 to the American Diabetes Association (ADA) for...
June 14, 2020 11:00 ET | Source: Zealand Pharma

Zealand Pharma presents clinical and non-clinical evidence for dasiglucagon rescue therapy at the 80th Scientific Sessions of the American Diabetes Association

Press release – No. 09 / 2020 Zealand Pharma presents clinical and non-clinical evidence for dasiglucagon rescue therapy at the 80th Scientific Sessions of the American Diabetes Association...
June 18, 2019 08:00 ET | Source: Amarantus Bioscience Holdings, Inc.

Amarantus Announces Positive Pre-Clinical Data for MANF in Wolfram Syndrome Presented at the 79th Annual Scientific Sessions of the American Diabetes Association

NEW YORK, NY, June 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Amarantus Bioscience Holdings, Inc. (OTC Pink: AMBS) (the “Company,” or AMBS), a US-based JLABS-alumnus biotechnology holding...
April 24, 2018 08:10 ET | Source: T1D Exchange

Finalists Announced for 2018 Diabetes Innovation Challenge

BOSTON, April 24, 2018 (GLOBE NEWSWIRE) -- T1D Exchange, a nonprofit patient-centered research organization dedicated to accelerating novel treatments to improve the lives of people with type 1...
March 20, 2018 08:15 ET | Source: T1D Exchange

Innovators From 17 Countries Vie for $250,000 in Cash and In-Kind Support to Advance Diabetes Care in the 2018 Diabetes Innovation Challenge

BOSTON, March 20, 2018 (GLOBE NEWSWIRE) -- T1D Exchange, a nonprofit research and collaboration organization dedicated to accelerating novel treatments to improve the care of people living with type...
January 29, 2018 12:30 ET | Source: Louisiana Public Health Institute

More than One Third of Louisiana Adults Have Prediabetes, Increased Risk for Serious Health Problems

New Orleans, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Across Louisiana, more than 35 percent of adults have prediabetes and are at an increased risk for serious health complications including kidney...
October 18, 2017 10:00 ET | Source: Solera Health

Solera Health and the American Diabetes Association® Collaborate to Help Prevent and Delay Type 2 Diabetes for Millions of Americans

PHOENIX, Oct. 18, 2017 (GLOBE NEWSWIRE) -- Solera Health (Solera), a preventive care benefits manager, today announced that they have joined forces with the American Diabetes Association...
June 16, 2017 07:51 ET | Source: Xeris Pharmaceuticals, Inc.

Xeris Pharmaceuticals Announces New Results From Ready-To-Use Liquid Glucagon Clinical Development Program

CHICAGO, IL and AUSTIN, TX, June 16, 2017 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (“Xeris”) announced today that results from three clinical studies of the company’s investigational...

Next Page keyboard_arrow_right